Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout ...
UC San Francisco scientists used CRISPRa to boost healthy SCN2A gene expression in mice, reducing seizures and restoring ...
A fresh wave of gene-editing therapies is surging to the fore — even as the field wrestles with the challenge of getting the first generation of expensive and complex CRISPR treatments to the people ...
A groundbreaking study reveals genetics—not diet or alcohol—are the primary cause of gout, challenging long-held myths and ...
Following the landmark approval of the first CRISPR-based cell therapy in December 2023, the CRISPR community is looking ahead to the next wave of commercial successes, fueled by continued innovation ...
Nearly a year after its approval, the first medical treatment that uses the Nobel Prize–winning technology Crispr is now being given to patients. Called Casgevy, the gene-editing treatment is for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback